JPH05501956A - 豚胸膜肺炎用ワクチン - Google Patents
豚胸膜肺炎用ワクチンInfo
- Publication number
- JPH05501956A JPH05501956A JP3500474A JP50047491A JPH05501956A JP H05501956 A JPH05501956 A JP H05501956A JP 3500474 A JP3500474 A JP 3500474A JP 50047491 A JP50047491 A JP 50047491A JP H05501956 A JPH05501956 A JP H05501956A
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- hemolysin
- sequence
- dna
- dna sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010035664 Pneumonia Diseases 0.000 title claims description 32
- 241000204031 Mycoplasma Species 0.000 title claims description 23
- 201000006509 pleuropneumonia Diseases 0.000 title claims description 23
- 229960005486 vaccine Drugs 0.000 title description 9
- 239000000427 antigen Substances 0.000 claims description 51
- 108091007433 antigens Proteins 0.000 claims description 51
- 102000036639 antigens Human genes 0.000 claims description 51
- 108010006464 Hemolysin Proteins Proteins 0.000 claims description 48
- 239000003228 hemolysin Substances 0.000 claims description 48
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 42
- 108090000623 proteins and genes Proteins 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 30
- 101150050411 appA gene Proteins 0.000 claims description 29
- 239000013598 vector Substances 0.000 claims description 26
- 101100148259 Actinobacillus pleuropneumoniae apxIIA gene Proteins 0.000 claims description 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 18
- 108020004414 DNA Proteins 0.000 claims description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 17
- 241000282887 Suidae Species 0.000 claims description 16
- 229920001184 polypeptide Polymers 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 9
- 230000000890 antigenic effect Effects 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000004071 biological effect Effects 0.000 claims description 6
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241001072332 Monia Species 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 101710147195 Hemolysin A Proteins 0.000 claims description 2
- 108020004511 Recombinant DNA Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 238000002955 isolation Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 11
- 101150070943 appC gene Proteins 0.000 description 11
- 230000002949 hemolytic effect Effects 0.000 description 11
- 238000012216 screening Methods 0.000 description 10
- 241001515965 unidentified phage Species 0.000 description 9
- 238000012300 Sequence Analysis Methods 0.000 description 8
- FBUKMFOXMZRGRB-UHFFFAOYSA-N Coronaric acid Natural products CCCCCC=CCC1OC1CCCCCCCC(O)=O FBUKMFOXMZRGRB-UHFFFAOYSA-N 0.000 description 7
- 101710170970 Leukotoxin Proteins 0.000 description 7
- 101150015540 apxIIC gene Proteins 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 241000282898 Sus scrofa Species 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000000523 sample Substances 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 231100000599 cytotoxic agent Toxicity 0.000 description 3
- 239000002619 cytotoxin Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 101710112752 Cytotoxin Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 241001293418 Mannheimia haemolytica Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000000753 anti-hemolysin Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 101100346656 Drosophila melanogaster strat gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 108020005350 Initiator Codon Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101150005926 Pc gene Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010058824 Pulmonary necrosis Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005520 electrodynamics Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 230000009083 hemolysis by symbiont of host erythrocytes Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical group 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (18)
- 1.A.プリューロニューモニア溶血素をコードするDNA配列を含む精製単離 されたDNA配列又はその対立変種。
- 2.DNA配列がさらに図1に示すappCAヌクレオチド配列を含むものとし て定義される請求の範囲1記載のDNA配列又はその対立変種。
- 3.ヌクレオチド配列がさらに図1に示すappCAアミノ酸配列又はこのアミ ノ酸と実質的に同一の配列及び生物活性を有するポリペプチドをコードするもの として定義される請求の範囲1記載のDNA配列。
- 4.ヌクレオチド配列かさらに図1に示すappAアミノ酸配列又はこのアミノ 酸と実質的に同一の配列及び生物活性を有するポリペプチドをコードするものと して定義される請求の範囲1記載のDNA配列。
- 5.ヌクレオチド配列がさらに図1に示すappAヌクレオチド配列又はその対 立変種を含むものとして定義される請求の範囲1記載のDNA配列。
- 6.A.プリューロニューモニア溶血素の抗原決定基をコードする請求の範囲1 記載のDNA配列。
- 7.ATCC受託No.68135に含まれる配列に生物学的に対応するA.プ リューロニューモニア抗原をコードする請求の範囲1記載のDNA配列。
- 8.AppA遺伝子又はその対立変種がコードするアミノ酸配列、又は実質的に 同じアミノ酸配列及び生物活性を有するポリペプチドを含むA.プリューロニュ ーモニア溶血素抗原。
- 9.適当なキャリアー中に生物学的活性量のA.プリューロニューモニア溶血素 抗原を含む組成物。
- 10.請求の範囲1、2、3、4、5、6又は7記載のDNA酸例を含む組換え ベクター。
- 11.組換えベクターか総換えプラスミドである請求の範囲10記載の組換えベ クタ。
- 12.DNA配列が強いプロモーター配列に機能的に結合している請求の範囲1 0記載の組換えベクター。
- 13.請求の範囲1、2、3、4、5、6又は7記載のDNA配列を含む組換え 細胞。
- 14.組換え細胞が細菌である請求の範囲13記載の組換え細胞。
- 15.以下の工程を含むA.プリューロニューモニア溶血素抗原の製造方法:請 求の範囲14記載の組換え細胞を提供する工程、該細胞が該抗原を産生するよう な条件下で該細胞を培養混合物として培養する工程、及び 培養混合物から抗原を単離する工程。
- 16.生物学的活性量のA.プリューロニューモニア溶血素抗原を豚に導入する 工程を含む豚胸膜肺炎に対して豚をワクチン予防接種する方法。
- 17.A.プリューロニューモニア溶血素抗原がappA抗原である請求の範囲 16記載の方法。
- 18.A.プリューロニューモニア溶血素抗原がappCA抗原である請求の範 囲16記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/429,273 US5641653A (en) | 1989-10-31 | 1989-10-31 | DNA encoding Actinobacillus pleuropneumoniae hemolysin |
US429,273 | 1989-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05501956A true JPH05501956A (ja) | 1993-04-15 |
JP3236610B2 JP3236610B2 (ja) | 2001-12-10 |
Family
ID=23702554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50047491A Expired - Lifetime JP3236610B2 (ja) | 1989-10-31 | 1990-10-31 | 豚胸膜肺炎用ワクチン |
Country Status (12)
Country | Link |
---|---|
US (2) | US5641653A (ja) |
EP (2) | EP0617128B1 (ja) |
JP (1) | JP3236610B2 (ja) |
AT (2) | ATE223487T1 (ja) |
AU (1) | AU644829B2 (ja) |
CA (1) | CA2071863C (ja) |
DE (2) | DE69033999T2 (ja) |
DK (2) | DK0500736T3 (ja) |
ES (2) | ES2069099T3 (ja) |
GR (1) | GR3015878T3 (ja) |
HU (1) | HUT64596A (ja) |
WO (1) | WO1991006653A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0453024B1 (en) * | 1990-04-20 | 1995-05-31 | Akzo Nobel N.V. | Actinobacillus pleuropneumoniae subunit vaccine |
US5994525A (en) * | 1991-06-28 | 1999-11-30 | Kamp; Elbarte Margriet | Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins |
US5417971A (en) * | 1991-10-22 | 1995-05-23 | University Of Saskatchewan | Vaccines for Actinobacillus pleuropneumoniae |
AUPN631495A0 (en) * | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(I) |
AUPN631395A0 (en) * | 1995-11-02 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Vaccine and biological vector(II) |
US5925354A (en) * | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
EP0810283A3 (en) * | 1996-05-31 | 1997-12-10 | Akzo Nobel N.V. | Live attenuated RTX-procucing bacteria of the family Pasteurellaceae |
JPH1075774A (ja) | 1996-05-31 | 1998-03-24 | Akzo Nobel Nv | パスツレラ科の弱毒化rtx産生細菌 |
AU6969798A (en) * | 1997-04-15 | 1998-11-11 | Baylor College Of Medicine | (pasteurella haemolytica) vaccine |
US6669940B2 (en) * | 2000-04-25 | 2003-12-30 | Kansas University Research Foundation | Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
WO2001080886A2 (en) * | 2000-04-25 | 2001-11-01 | Kansas State University Research Foundation | Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
ATE486936T1 (de) * | 2003-03-05 | 2010-11-15 | Chemo Sero Therapeut Res Inst | Verfahren zur herstellung eines heterologen proteins in e. coli |
CN109453371A (zh) * | 2018-11-23 | 2019-03-12 | 中国兽医药品监察所 | 一种羊痘、山羊传染性胸膜肺炎二联灭活疫苗及其生产方法 |
WO2021229721A1 (ja) | 2020-05-13 | 2021-11-18 | 三菱電機株式会社 | 空中ハプティクス制御装置、空中ハプティクスシステム及び空中ハプティクス制御方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8802007A (nl) * | 1988-08-12 | 1990-03-01 | Centraal Diergeneeskundig Inst | Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins. |
-
1989
- 1989-10-31 US US07/429,273 patent/US5641653A/en not_active Expired - Lifetime
-
1990
- 1990-10-31 EP EP94108311A patent/EP0617128B1/en not_active Expired - Lifetime
- 1990-10-31 DK DK90917398.1T patent/DK0500736T3/da active
- 1990-10-31 EP EP90917398A patent/EP0500736B1/en not_active Expired - Lifetime
- 1990-10-31 ES ES90917398T patent/ES2069099T3/es not_active Expired - Lifetime
- 1990-10-31 DE DE69033999T patent/DE69033999T2/de not_active Expired - Fee Related
- 1990-10-31 JP JP50047491A patent/JP3236610B2/ja not_active Expired - Lifetime
- 1990-10-31 DK DK94108311T patent/DK0617128T3/da active
- 1990-10-31 AU AU67513/90A patent/AU644829B2/en not_active Ceased
- 1990-10-31 WO PCT/US1990/006350 patent/WO1991006653A1/en active IP Right Grant
- 1990-10-31 CA CA002071863A patent/CA2071863C/en not_active Expired - Lifetime
- 1990-10-31 DE DE69016671T patent/DE69016671T2/de not_active Expired - Fee Related
- 1990-10-31 AT AT94108311T patent/ATE223487T1/de not_active IP Right Cessation
- 1990-10-31 AT AT90917398T patent/ATE118038T1/de not_active IP Right Cessation
- 1990-10-31 HU HU9201413A patent/HUT64596A/hu unknown
- 1990-10-31 ES ES94108311T patent/ES2181695T3/es not_active Expired - Lifetime
-
1995
- 1995-04-19 GR GR950401014T patent/GR3015878T3/el unknown
-
1997
- 1997-05-02 US US08/850,379 patent/US5804190A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0617128A1 (en) | 1994-09-28 |
DK0617128T3 (da) | 2002-12-02 |
EP0500736A1 (en) | 1992-09-02 |
GR3015878T3 (en) | 1995-07-31 |
HUT64596A (en) | 1994-01-28 |
US5641653A (en) | 1997-06-24 |
DE69016671D1 (de) | 1995-03-16 |
ATE118038T1 (de) | 1995-02-15 |
CA2071863A1 (en) | 1991-05-01 |
AU644829B2 (en) | 1993-12-23 |
EP0617128B1 (en) | 2002-09-04 |
US5804190A (en) | 1998-09-08 |
EP0500736B1 (en) | 1995-02-01 |
DE69033999D1 (de) | 2002-10-10 |
CA2071863C (en) | 2007-08-07 |
JP3236610B2 (ja) | 2001-12-10 |
ES2181695T3 (es) | 2003-03-01 |
ATE223487T1 (de) | 2002-09-15 |
DE69016671T2 (de) | 1995-08-10 |
DE69033999T2 (de) | 2003-07-31 |
WO1991006653A1 (en) | 1991-05-16 |
ES2069099T3 (es) | 1995-05-01 |
AU6751390A (en) | 1991-05-31 |
DK0500736T3 (da) | 1995-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU690570B2 (en) | High level expression, purification and refolding of the neisseria meningitidis outer membrane group B porin proteins | |
JP3205932B2 (ja) | ライム病に対するワクチン、その取得法、モノクローナル抗体、抗原、組換えdna、組換えベクター及び抗原の取得法 | |
FI107334B (fi) | Menetelmä rokotteen valmistamiseksi Lymen taudin estämiseksi | |
DE69430246T2 (de) | Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen | |
JP2001204482A (ja) | 肺炎球菌タンパクの構造遺伝子 | |
JP4091112B2 (ja) | リポタンパク質の発現 | |
JP2577280B2 (ja) | 組換えポックスウイルス及び連鎖球菌mタンパク質ワクチン | |
JPH04501051A (ja) | 組換え型dna由来ボルデテラ毒素サブユニット類似体 | |
JP2008249712A (ja) | ヒスチジンタグ付きインチミン、ならびに免疫応答を刺激し、標的能力を有する抗原担体としてインチミンを使用する方法 | |
EP0807178A1 (fr) | Proteines de mycobacteries, microorganismes les produisant et leurs utilisations vaccinales et pour la detection de la tuberculose | |
JPH05501956A (ja) | 豚胸膜肺炎用ワクチン | |
WO2016155605A1 (zh) | 肺炎链球菌蛋白抗原及其制备方法和应用 | |
US5869064A (en) | Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition | |
JPH0866198A (ja) | 肺炎球菌の表面タンパクaのエピトープ領域 | |
JPH01500117A (ja) | 免疫増強作用系 | |
JPH09512703A (ja) | 空胞形成毒素欠損H.pyloriおよび関連する方法 | |
US5695956A (en) | Clostridium perfingens type a enterotoxin toxoid and methods of preparation and use as a vaccine and therapeutic agent | |
US5281694A (en) | Methods and compositions for production of mycoplasmal adhesins | |
AU614754B2 (en) | Treatment and diagnosis of footrot using the basic protease of b.nodosus. | |
JP2002539763A (ja) | ヘリコバクター・ピロリ抗原 | |
JP3140776B2 (ja) | 無細胞ワクチン | |
DK169749B1 (da) | DNA-fragment, der koder for et Pasteurella multocida-toxin eller for en immunogen subsekvens eller analog deraf, ekspressionsvektor, der omfatter DNA-fragmentet, fremgangsmåde til fremstilling af et Pasteurella multocida-toxin og anvendelse af Pasteurella multocida-toxinsekvens eller -analog til fremstilling af en vaccine | |
AU681130C (en) | Protein rib, a cell surface protein that confers immunity tomany strains of the group B streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition | |
JP2002512528A (ja) | ストレプトコッカス イクイの保護m−様タンパク質をコードする化合物及びその検定 | |
JP2004041084A (ja) | ヘリコバクター・ピロリ菌に対するワクチン用ペプチド、それをコードする遺伝子、その遺伝子が導入された形質転換体、及びそれらの利用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070928 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080928 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090928 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100928 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100928 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110928 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110928 Year of fee payment: 10 |